Search clinical trials for: Buprenorphine Transdermal System

Total 78185 results

Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
Purdue Pharma LP

Withdrawn

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain

Other Acute Postoperative Pain | Prolonged Endotracheal Intubation
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Norspan Transdermal Patches Study in Osteoarthritis Patients

Osteoarthritis Disorders

China
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
Security Forces Hospital

Recruiting

Role of Preoperative Transdermal Buprenorphine Patch in Reducing Postoperative Opioids Consumption in Patients Undergoing Total Knee Arthroplasties - A Randomised Controlled Trial.

Patients Aged Between 18 and 65years Undergoing Total Knee Arthroplasty

Saudi Arabia
Chinese Chronic Respiratory Disease Research Network

Recruiting

Lung Nodule Intervention Cohort Study (LNICS)

Incident Lung Nodule

China
Indivior Inc.

Completed

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

Opioid Dependence

United States
Braeburn Pharmaceuticals
Medpace, Inc.; Camurus AB

Completed

Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain (CAM2038)

Chronic Pain | Chronic Lower Back Pain

United States
University of Chicago

Completed

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology (BED)

Depression

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Buprenorphine

Obesity, Morbid

Norway
National Institute on Drug Abuse (NIDA)
Beth Israel Medical Center

Unknown

Sublingual Buprenorphine for Chronic Pain

Chronic Pain

United States
University of Wisconsin, Madison
University of Wisconsin, Milwaukee

Completed

Treatment for Opioid Dependent Offenders

Opioid Dependence

United States
Laura Fanucchi
National Institute on Drug Abuse (NIDA)

Recruiting

Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (BOPAT)

Drug Use | Opioid-use Disorder

United States
Indivior Inc.

Completed

Transfer of Subjects From Subutex/Suboxone to RBP-6300

Opioid Related Disorder

Austria, Czech Republic, Germany, Sweden
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Starting Treatment With Agonist Replacement Therapies (START)

Opiate-related Disorders

United States
University of California, Los Angeles

Not yet recruiting

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

Schizophrenia
Gangnam Severance Hospital

Completed

Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy

Laparoscopic Cholecystectomy

Korea, Republic of
New York State Psychiatric Institute

Completed

An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder

Opioid-use Disorder

United States
Abarbanel Mental Health Center
Ministry of Health, Israel

Unknown

A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality

Depression | Suicidal Ideation | Suicidal Action

Israel
Yale University
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Emergency Department-Initiated Buprenorphine Validation Network Trial

Opioid-use Disorder

United States
Indivior Inc.

Completed

SUBLOCADE Rapid Initiation Extension Study

Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe

United States
University of Vermont Medical Center

Completed

Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access (IBT)

Opioid-related Disorders

United States
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

Healthy

Germany
Banner Health
Phoenix Children's Hospital

Completed

Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

Toxicity

United States
INSYS Therapeutics Inc

Terminated

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Post-operative Pain

United States
BioDelivery Sciences International

Withdrawn

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Opioid Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals

Opioid Dependence | Opioid Abuse

United States
Titan Pharmaceuticals

Terminated

Study of Probuphine in Patients With Opioid Dependence (PRO-809)

Opioid Dependency

United States
State University of New York at Buffalo

Withdrawn

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Opiate Addiction

United States
MediBeacon

Recruiting

Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring

Kidney Diseases | Kidney Injury | Kidney Failure

United States
MediBeacon

Completed

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Chronic Kidney Disease

United States, China
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States
St. Louis University

Completed

Buprenorphine Dose Adjustments and Gestational Age

Neonatal Abstinence Syndrome
Oregon Health and Science University
Hanoi Medical University; Hennepin Healthcare Research Institute

Completed

Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)

HIV | Substance Related Disorders

Vietnam
PATH
London School of Hygiene and Tropical Medicine; Monash University; University... and other collaborators

Not yet recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Opioid Dependence
BioDelivery Sciences International

Withdrawn

Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

Opioid Dependence

United States
BioDelivery Sciences International

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Opioid Dependence

United States
US Department of Veterans Affairs
National Institute on Drug Abuse (NIDA); Reckitt and Colman

Completed

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Opiate Dependence

United States
Titan Pharmaceuticals

Completed

Re-Treatment Study of Probuphine in Opioid Addiction

Opioid Dependency

United States
Titan Pharmaceuticals

Completed

Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence (PRO-807)

Opioid Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department

Opiate Addiction

United States
Emory University
National Institute on Drug Abuse (NIDA); Chestnut Health Systems

Withdrawn

Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use (A-CRA/MAT)

Behavior, Addictive | Opioid-Related Disorders
Indivior Inc.

Completed

Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder

Opioid Use Disorder

United States
Johns Hopkins University

Recruiting

Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (BIPOD-Out)

Opioid Use Disorder

United States
Indivior Inc.

Completed

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

Opioid Use Disorder

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); The City University of New York; Washington...

Completed

Pilot Test of a Community-based Buprenorphine Treatment Intervention

Opioid Dependence | Injection Drug Use

United States
Indivior Inc.

Completed

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

Opioid Related Disorder

United States
Didier Jutras Aswad
Canadian Institutes of Health Research (CIHR)

Completed

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA)

Opioid Use Disorder

Canada
State University of New York at Buffalo
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse...

Completed

Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

Opiate Addiction

United States

Search clinical trials for: Buprenorphine Transdermal System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations